Inventor · disambiguated record
Ronald L. Wolin
Also filed as: WOLIN RONALD · WOLIN RONALD L
52 granted patents·11 pending applications·701 citations·filing 1995–2023
98Inventor score
Files withJANSSEN PHARMACEUTICA NV27SCHERING CORP23ORTHO MCNEIL PHARM INC3APODACA RICHARD2BREITENBUCHER J GUY2
Top patents by PatentIndex Score
63 records- 0196US9221804B2Secondary alcohol quinolinyl modulators of RORγtJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Dec 29, 2015·35 cites·23 claims
- 0293US9290476B2Methylene linked quinolinyl modulators of RORγtJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Mar 22, 2016·31 cites·27 claims
- 0392US5719148ATricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseasesSCHERING CORP·Filed 1995·Granted Feb 17, 1998·92 cites·47 claims
- 0490US10369146B2Phenyl linked quinolinyl modulators of RORγtJANSSEN PHARMACEUTICA NV·Filed 2016·Granted Aug 6, 2019·5 cites·13 claims
- 0590US5721236ATricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseasesSCHERING CORP·Filed 1995·Granted Feb 24, 1998·72 cites·11 claims
- 0688US9284308B2Methylene linked quinolinyl modulators of RORγtJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Mar 15, 2016·6 cites·21 claims
- 0787US11254673B2Small molecule inhibitors of NF-κB inducing kinaseJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Feb 22, 2022·2 cites·13 claims
- 0887US9309222B2Phenyl linked quinolinyl modulators of RORγtJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Apr 12, 2016·13 cites·25 claims
- 0987US6075025ATricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseasesSCHERING CORP·Filed 1998·Granted Jun 13, 2000·34 cites·8 claims
- 1086US6242458B1Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseasesSCHERING CORP·Filed 1999·Granted Jun 5, 2001·25 cites·8 claims
- 1185US9328095B2Heteroaryl linked quinolinyl modulators of RORgammatJANSSEN PHARMACEUTICA NV·Filed 2013·Granted May 3, 2016·3 cites·5 claims
- 1285US6908929B2Phenyl-substituted imidazopyridinesORTHO MCNEIL PHARM INC·Filed 2001·Granted Jun 21, 2005·17 cites·21 claims
- 1385US5696121ATricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseasesSCHERING CORP·Filed 1995·Granted Dec 9, 1997·50 cites·6 claims
- 1484US9403816B2Phenyl linked quinolinyl modulators of RORγtJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Aug 2, 2016·3 cites·5 claims
- 1583US6365588B1Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseasesSCHERING CORP·Filed 1999·Granted Apr 2, 2002·22 cites·11 claims
- 1682US7718702B2Cannabinoid receptor ligandsSCHERING CORP·Filed 2005·Granted May 18, 2010·5 cites·34 claims
- 1782US7067539B2Cannabinoid receptor ligandsSCHERING CORP·Filed 2002·Granted Jun 27, 2006·18 cites·31 claims
- 1881US8841287B2Diamino-pyridine, pyrimidine, and pyrazine modulators of the histamine H4 receptorCAI HUI·Filed 2009·Granted Sep 23, 2014·6 cites·31 claims
- 1979US9624225B2Quinolinyl modulators of RORγtJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Apr 18, 2017·3 cites·10 claims
- 2079US9303015B2Heteroaryl linked quinolinyl modulators of RORγtJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Apr 5, 2016·4 cites·24 claims
- 2179US6492381B1Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseasesSCHERING CORP·Filed 2000·Granted Dec 10, 2002·7 cites·9 claims
- 2279US6100279AImidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atomSCHERING CORP·Filed 1998·Granted Aug 8, 2000·53 cites·23 claims
- 2379US5728703ATricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseasesSCHERING CORP·Filed 1995·Granted Mar 17, 1998·34 cites·16 claims
- 2478US5807853ATricyclic amide and urea compounds, useful inhibition of g-protein function and for treatment of proliferative diseasesSCHERING CORP·Filed 1995·Granted Sep 15, 1998·18 cites·22 claims
- 2578US5684013ATricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseasesSCHERING CORP·Filed 1995·Granted Nov 4, 1997·35 cites·8 claims
- 2677US9346782B2Alkyl linked quinolinyl modulators of RORγtJANSSEN PHARMACEUTICA NV·Filed 2014·Granted May 24, 2016·3 cites·6 claims
- 2776US7507767B2Cannabinoid receptor ligandsSCHERING CORP·Filed 2002·Granted Mar 24, 2009·8 cites·37 claims
- 2876US6440989B2Phenyl-substituted tricyclic inhibitors of farnesyl-protein transferaseSCHERING CORP·Filed 2001·Granted Aug 27, 2002·7 cites·8 claims
- 2976US2024199605A1SMALL MOLECULAR INHIBITORS OF NF-kB INDUCING KINASEJANSSEN PHARMACEUTICA NV·Filed 2023·Application pending·0 cites
- 3075US11827634B2Small molecule inhibitors of NF-kB inducing kinaseJANSSEN PHARMACEUTICA NV·Filed 2021·Granted Nov 28, 2023·0 cites·31 claims
- 3174US5703090ATricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseasesSCHERING CORP·Filed 1996·Granted Dec 30, 1997·33 cites·8 claims
- 3270US6218401B1Phenyl-substituted tricyclic inhibitors of farnesyl-protein transferaseSCHERING CORP·Filed 1999·Granted Apr 17, 2001·10 cites·5 claims
- 3369US5958939ATricyclic compounds useful for inhibition of a g-protein function and for treatment of proliferative diseasesSCHERING CORP·Filed 1997·Granted Sep 28, 1999·26 cites·8 claims
- 3468US7087757B2Phenyl-substituted imidazopyridinesORTHO MCNEIL PHARM INC·Filed 2004·Granted Aug 8, 2006·2 cites·3 claims
- 3566US7276610B2Aryl piperidine amidesJANSSEN PHARACEUTICA NV·Filed 2004·Granted Oct 2, 2007·5 cites·7 claims
- 3664US7041828B2Phenyl-substituted imidazopyridinesBREITENBUCHER J GUY·Filed 2004·Granted May 9, 2006·1 cites·4 claims
- 3762US2025282785A1Pyrrolidinone derivatives as inhibitors of nf kappa b inducing kinaseJANSSEN PHARMACEUTICA NV·Filed 2023·Application pending·0 cites
- 3861US8686142B22-aminopyrimidine modulators of the histamine H4 receptorJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Apr 1, 2014·0 cites·1 claims
- 3961US6762186B2Substituted imidazoles as dual histamine H1 and H3 agonists or antagonistsSCHERING CORP·Filed 2001·Granted Jul 13, 2004·1 cites·7 claims
- 4061US2025304567A1Pyrrolidione derivatives as inhibitors of nf kappa b inducing kinaseJANSSEN PHARMACEUTICA NV·Filed 2023·Application pending·0 cites
- 4159US9732087B2Diamino-pyridine, pyrimidine, and pyridazine modulators of the histamine H4 receptorJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Aug 15, 2017·0 cites·21 claims
- 4259US7199117B2Phenyl-substituted imidazopyridinesORTHO MCNEIL PHARM INC·Filed 2004·Granted Apr 3, 2007·0 cites·9 claims
- 4359US7041827B2Phenyl-substituted imidazopyridinesBREITENBUCHER J GUY·Filed 2004·Granted May 9, 2006·0 cites·6 claims
- 4457US2002068742A1Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseasesFiled 2001·Application pending·0 cites
- 4556US2023416256A1SMALL MOLECULE INHIBITORS OF NF-kB INDUCING KINASEJANSSEN PHARMACEUTICA NV·Filed 2021·Application pending·0 cites
- 4655US7915420B2Aryl piperidine amidesJANSSEN PHARMACEUTICA NV·Filed 2007·Granted Mar 29, 2011·0 cites·6 claims
- 4755US2011218338A12-aminopyrimidine modulators of the histamine h4 receptorJanseen Pharmaceutiacal NV·Filed 2011·Application pending·0 cites
- 4853US7754882B2Hexahydro-pyrrolo-isoquinoline compoundsJANSSEN PHARMACEUTICA NV·Filed 2006·Granted Jul 13, 2010·0 cites·19 claims
- 4951US2016136149A1HETEROARYL LINKED QUINOLINYL MODULATORS OF RORytJANSSEN PHARMACEUTICA NV·Filed 2016·Application pending·0 cites
- 5051US2017298022A1Diamino-Pyridine, Pyrimidine, and Pyridazine Modulators of the Histamine H4 ReceptorJANSSEN PHARMACEUTICA NV·Filed 2017·Application pending·0 cites
Showing the top 50 of 63 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Ronald L. Wolin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →